Catalyst Pharmaceuticals Inc (CPRX)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	491,734	460,482	434,475	411,347	398,204	348,393	302,949	256,480	214,203	191,755	170,465	153,717	140,833	133,539	126,902	120,142	119,073	118,181	119,761	118,994
Property, plant and equipment	US$ in thousands	—	—	—	—	—	—	3,844	1,285	847	882	917	925	3,976	951	4,115	944	130	149	168	197
Fixed asset turnover		—	—	—	—	—	—	78.81	199.60	252.90	217.41	185.89	166.18	35.42	140.42	30.84	127.27	915.95	793.16	712.86	604.03

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $491,734K ÷ $—K
= —

The fixed asset turnover ratio for Catalyst Pharmaceuticals Inc has fluctuated over the reported periods. The ratio increased from 604.03 in March 31, 2020, to a peak of 915.95 in December 31, 2020, indicating the company was generating significant sales revenue relative to its fixed assets during this period.

However, there was a sharp decline in the fixed asset turnover to 30.84 in June 30, 2021, and further to 35.42 in December 31, 2021. These low values suggest that the company's fixed assets were not being utilized efficiently to generate sales.

The ratio recovered slightly to 166.18 in March 31, 2022, and increased gradually in the following periods, reaching 252.90 by December 31, 2022. This improvement indicates that Catalyst Pharmaceuticals Inc may have optimized its fixed asset utilization to drive sales growth during this time.

The ratio experienced some fluctuations in the subsequent periods, with values of 199.60 in March 31, 2023, and 78.81 in June 30, 2023. Notably, the data is missing for the periods after September 30, 2023, which limits a complete analysis of the company's recent fixed asset turnover performance.

Overall, the trend in Catalyst Pharmaceuticals Inc's fixed asset turnover ratio shows periods of both efficiency and inefficiency in utilizing fixed assets to generate sales revenue, suggesting fluctuations in operational performance and potential areas for improvement in asset management.